Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of ABT-751 in Patients With Breast Cancer Refractory to Taxane Regimens

NCT00063102 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00063102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00063102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of ABT-751 in Patients With Breast Cancer Refractory to Taxane Regimens
Lead sponsor
Abbott
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2002
Completion date
August 31, 2004
Enrollment
40
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer